Ocular inflammation in cynomolgus macaques following intravenous administration of a human monoclonal antibody
International journal of toxicology, 28(1), pp.5-16
Therapy Development
Retinal effects of 6 months of daily use of tadalafil or sildenafil
Archives of ophthalmology, 127(4), pp.367-373
Ocular and systemic safety evaluation of calcium formate as a dietary supplement
Journal of ocular pharmacology and therapeutics, 25(3), pp.223-230
Evaluation of EIAV Based Lentiviral Vectors Following Ocular Delivery in the Nonhuman Primate Model: Development of RetinoStat®
Investigative Ophthalmology & Visual Science, 49(13), pp.5340-5340
Bimatoprost, prostamide activity, and conventional drainage
Investigative ophthalmology & visual science, 48(9), pp.4107-4115
Investigation of ocular events associated with taprenepag isopropyl, a topical EP2 agonist in development for treatment of glaucoma
J Ocul Pharmacol Ther. 2014 Jun;30(5):429-39. doi: 10.1089/jop.2013.0222. Epub 2014 Apr 10.
ABSTRACT
Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin
Hum Gene Ther Clin Dev. 2015 Sep;26(3):165-76. doi: 10.1089/humc.2015.076.
ABSTRACT
Safety and Biodistribution Evaluation in CNGB3-Deficient Mice of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia
Hum Gene Ther Clin Dev. 2016 Mar;27(1):27-36. doi: 10.1089/humc.2015.163.
ABSTRACT
Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia
Hum Gene Ther Clin Dev. 2016 Mar;27(1):37-48. doi: 10.1089/humc.2015.164.
ABSTRACT
Ocular toxicity of AUY922 in pigmented and albino rats
Toxicol Appl Pharmacol. 2016 Oct 15;309:55-62. doi: 10.1016/j.taap.2016.08.025. Epub 2016 Aug 28.
ABSTRACT